GSK (LON:GSK) Earns “Underweight” Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK) in a research report report published on Tuesday, MarketBeat Ratings reports.

GSK has been the subject of several other reports. Deutsche Bank Aktiengesellschaft reaffirmed a buy rating and issued a GBX 1,950 ($24.66) target price on shares of GSK in a research report on Friday, June 28th. Barclays reissued an equal weight rating and set a GBX 1,725 ($21.82) price objective on shares of GSK in a research report on Tuesday, May 7th. Citigroup reissued a buy rating and set a GBX 2,100 ($26.56) price objective on shares of GSK in a research report on Monday, June 24th. Jefferies Financial Group reissued a buy rating and set a GBX 2,100 ($26.56) price objective on shares of GSK in a research report on Thursday, June 27th. Finally, Shore Capital reissued a buy rating on shares of GSK in a research report on Thursday, June 27th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and an average price target of GBX 1,791.25 ($22.66).

GSK Stock Performance

LON GSK opened at GBX 1,510.50 ($19.11) on Tuesday. The company has a market cap of £61.63 billion, a P/E ratio of 1,382.57, a P/E/G ratio of 1.19 and a beta of 0.27. The company has a debt-to-equity ratio of 134.34, a current ratio of 0.87 and a quick ratio of 0.73. The stock has a 50-day moving average of GBX 1,677.97 and a two-hundred day moving average of GBX 1,632.42. GSK has a 1-year low of GBX 1,302.60 ($16.48) and a 1-year high of GBX 1,823.50 ($23.06).

GSK Cuts Dividend

The firm also recently declared a dividend, which will be paid on Thursday, July 11th. Investors of record on Thursday, May 16th will be issued a GBX 15 ($0.19) dividend. This represents a yield of 0.9%. The ex-dividend date is Thursday, May 16th. GSK’s dividend payout ratio (DPR) is 5,504.59%.

Insider Activity at GSK

In other GSK news, insider Wendy Becker purchased 446 shares of the stock in a transaction that occurred on Thursday, June 20th. The stock was purchased at an average cost of GBX 1,614 ($20.41) per share, with a total value of £7,198.44 ($9,105.03). 1.60% of the stock is currently owned by corporate insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.